InNexus Biotechnology has named Jeff Morhet as its new CEO and president. He succeeds Dr. Charles Morgan, who co-founded the company.

DOR BioPharma has appointed Christopher J. Schaber, Ph.D., as its new president and CEO to replace Michael T. Sember.

Synthetech has appointed Dr. Gregory Hahn as president and COO.

The former chief medical officer of Chiron BioPharmaceuticals, Stephen G. Dilly, M.B.B.S., Ph.D., has been named CEO of APT Pharmaceuticals.

Alpharma said that CFO Matthew T. Farrell has resigned to join another company.

Paul J. Price, Ph.D. has been named the chief scientific officer of D-Finitive Technologies.

Watson Pharmaceuticals has appointed Thomas R. Russillo executive vice president and president, U.S. Generics Division.

Idenix Pharmaceuticals has appointed John F. Weidenbruch to the position of executive vice president and general counsel.

Lipomics Technologies has hired Dr. Meeta Patnaik, MD for the newly created position of chief medical officer.

Adnexus Therapeutics has expanded its management team. Eric S. Furfine, Ph.D. holds the position of senior vice president of research and preclinical development, Charles R. Carter is the company's vice president, finance, and Erin E. Lanciani assumes the role vice president, human resources.

MDS Pharma Services has hired two industry experts: Dr. Claudio Carini, a leader for his work in developing and applying biomarkers to indicate the risk, presence and progression of diseases; and Suzanne Sensabaugh, recognized for her regulatory expertise in helping clients in the development of biopharmaceuticals.

MediciNova has named Mr. Okajima as vice president and head of the Japanese office.

Tasco Holdings is beginning a nationwide search for a quality assurance and regulatory affairs director.

ACCESS Pharmaceuticals has appointed Mark J. Ahn, Ph.D. to the board of directors of the company. In addition, Max Link, Ph.D., a board member since 1996, has announced his resignation.

EndGenitor Technologies has named Guido J. Neels to its board of directors.

Xenomics has named David Sidransky, M.D., of Johns Hopkins University to its board of directors.

Solexa has appointed A. Blaine Bowman and Roy A. Whitfield to its board of directors.

Surface Logix announced the appointment of W. James O'Shea to the company's board of directors.